Syndax Pharmaceuticals, Inc. — Key Metrics
46 years of history · ending 2025-12-31 · SEC EDGAR
QuarterlyAnnual
EPS (Diluted)↑+11.5% +$0
$-3
Book Value Per Share↓-77.8% -$3
$1
Free Cash Flow Per Share↓-16.2% -$1
$-4
Return on Equity↓-219.6pts
-317.0%
Return on Assets↑+2.6pts
-52.8%
Return on Invested Capital↓-157.6pts
-239.6%
Current Ratio↓-24.5% -$1
4.40
Quick Ratio↓-29.1% -$2
4.12
Asset Turnover↑+674.4% +$0
0.32